Phase 1: During tapering Ensure adequate protein intake Adopt a sustainable low-carbohydrate or ketogenic diet and begin tracking ketones, along with glucose if you have diabetes or prediabetes Incorporate exercise, especially resistance training Phase 2: First 48 weeks after stopping Expect appetite to increase Maintain regular, structured meals using keto-friendly recipes Continue monitoring metabolic trends Phase 3: Long-term maintenance Use periodic tracking of your weight, ketones and/or glucose as needed Adjust food intake and activity based on your results How to Know If Youre Maintaining Fat Loss The Role of Muscle in Long-Term Success Preserving lean mass is an important component of long-term weight maintenance
The level of VEGF-A significantly increased from 75.6 to 138.6 pg/mL in high glucose (HG)-stimulated human retinal endothelial cells (HRECs) but decreased to 102.1 pg/mL and 92.5 pg/mL with 50 nM and 100 nM liraglutide, respectively
Since GLP-1 receptor agonists stimulate the release of insulin, the hormone responsible for moving sugar out of the blood and into cells to be used, maintaining steady blood sugar levels helps these medications work effectively
Common GLP-1-based medications include: Semaglutide (brand names: Wegovy, Ozempic) Tirzepatide (brand names: Zepbound, Mounjaro) Retatrutide (currently an investigational medication and not yet FDA-approved for weight loss) These medications work best when combined with a healthy diet, regular physical activity, and sustainable lifestyle changes
)
